RT Journal Article
T1 The ERA Registry Annual Report 2019: summary and age comparisons.
A1 Boenink, Rianne
A1 Astley, Megan E
A1 Huijben, Jilske A
A1 Stel, Vianda S
A1 Kerschbaum, Julia
A1 Ots-Rosenberg, Mai
A1 Åsberg, Anders A
A1 Lopot, Frantisek
A1 Golan, Eliezer
A1 Castro de la Nuez, Pablo
A1 Rodríguez Camblor, Marta
A1 Trujillo-Alemán, Sara
A1 Ruiz San Millan, Juan Carlos
A1 Ucio Mingo, Pablo
A1 Díaz, Juan Manuel
A1 Bouzas-Caamaño, M Encarnación
A1 Artamendi, Marta
A1 Aparicio Madre, Manuel I
A1 Santiuste de Pablos, Carmen
A1 Slon Roblero, María Fernanda
A1 Zurriaga, Oscar
A1 Stendahl, Maria E
A1 Bell, Samira
A1 Idrizi, Alma
A1 Ioannou, Kyriakos
A1 Debska-Slizien, Alicja
A1 Galvão, Ana A
A1 De Meester, Johan M
A1 Resić, Halima
A1 Hommel, Kristine
A1 Radunovic, Danilo
A1 Pálsson, Runolfur
A1 Lassalle, Mathilde
A1 Finne, Patrik
A1 De Los Ángeles-Garcia Bazaga, María
A1 Gjorgjievski, Nikola
A1 Seyahi, Nurhan
A1 Bonthuis, Marjolein
A1 Ortiz, Alberto
A1 Jager, Kitty J
A1 Kramer, Anneke
K1 ESRD
K1 dialysis
K1 epidemiology
K1 graft survival
K1 kidney transplantation
K1 patient survival
AB Data on renal replacement therapy (RRT) for end-stage renal disease were collected by the European Renal Association (ERA) Registry via national and regional renal registries in Europe and countries bordering the Mediterranean Sea. This article provides a summary of the 2019 ERA Registry Annual Report, including data from 34 countries and additional age comparisons. Individual patient data for 2019 were provided by 35 registries and aggregated data by 17 registries. Using these data, the incidence and prevalence of RRT, the kidney transplantation activity and the survival probabilities were calculated. In 2019, a general population of 680.8 million people was covered by the ERA Registry. Overall, the incidence of RRT was 132 per million population (p.m.p.). Of these patients, 62% were men, 54% were ≥65 years of age and 21% had diabetes mellitus as primary renal disease (PRD), and 84% had haemodialysis (HD), 11% had peritoneal dialysis (PD) and 5% had pre-emptive kidney transplantation as an initial treatment modality. The overall prevalence of RRT on 31 December 2019 was 893 p.m.p., with 58% of patients on HD, 5% on PD and 37% living with a kidney transplant. The overall kidney transplant rate was 35 p.m.p. and 29% of the kidney grafts were from a living donor. The unadjusted 5-year survival probability was 42.3% for patients commencing dialysis, 86.6% for recipients of deceased donor grafts and 94.4% for recipients of living donor grafts in the period 2010-14. When comparing age categories, there were substantial differences in the distribution of PRD, treatment modality and kidney donor type, and in the survival probabilities.
SN 2048-8505
YR 2021
FD 2021-12-15
LK http://hdl.handle.net/10668/19740
UL http://hdl.handle.net/10668/19740
LA en
DS RISalud
RD Apr 11, 2025